Brandfon S, Eylon A, Khanna D, Parmar MS
Topline Novo Nordisks weight loss injection semaglutide the ingredient inside its wildly popular drugs Ozempic and Wegovy could also help protect the kidneys, according to new research, a finding that bolsters the growing public health case for the drug amid ongoing concerns over costs and short supplies
Wegovy, Zepbound, and Saxenda are alternatives to Semaglutide for weight loss
That said, FDA approval is never guaranteed and depends entirely on final clinical trial outcomes, regulatory review, manufacturing readiness, and whether the FDA determines that the benefits outweigh the risks for public use
Large meta-analyses and pooled data from randomized controlled trials demonstrate that GLP-1 receptor agonists do not increase the risk of depression, anxiety, suicidality, or other serious psychiatric adverse events compared to placebo
21.0% of UK adults using weight-loss injectables now obtain them without a prescription